● Sohn SY, Kim YJ, Doh JH, Cho SW. Moderate-Intensity Atorvastatin and Ezetimibe Combination Therapy Versus High-Intensity Atorvastatin in Patients with Angina Pectoris who Underwent Percutaneous Coronary Intervention Cardiovasc Drugs Ther. 2025. Aug 22. doi: 10.1007/s10557-025-07729-7. Online ahead of print.

● Lee JY, Hong M, Jung YH, Sohn SY. Risk of psychiatric disorders in patients with graves' disease: A nationwide population-based analysis. J Affect Disord. 2025 Sep 15:385:119386 

● Sohn SY, Kim YJ, Cho S, Cho SW. Incidence and Risk Factors for Amiodarone-Induced Thyroid Dysfunction: A Nationwide Retrospective Cohort Study. Am J Cardiovasc Drugs. 2025 May;25(3):419-425. 

● Lee JY, Lee MK, Lee JH, Kim K, Bae K, Sohn SY. Cancer Risks of Patients with Graves' Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis. Thyroid. 2024 Oct;34(10):1271-1279. 

● Sohn SY, Inoue K, Rhee CM, Leung AM. Risks of Iodine Excess. Endocr Rev 2024 Nov 22;45(6):858-879. 

● Sohn SY, Inoue K, Bashir MT, Currier JW, Neverova NV, Ebrahimi R, Rhee CM, Lee ML, Leung AM. Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis. J Clin Endocrinol Metab. 2025 Mar 17;110(4):e1204-e1210. 

● Sohn SY, Ahn J, Lee MK, Lee JH, Kwon JW, Kweon JM, Lee JY. Risk of non-thyroidal autoimmune diseases in patients with Graves' disease: a nationwide retrospective cohort study. Rheumatology (Oxford). 2025 Jan 1;64(1):303-309 

● Lee JY, Park SY, Sohn SY. Increased risk of incident gout in patients with hyperthyroidism: a nationwide retrospective cohort study Rheumatol Int 2023 Aug 18. 

● Ahn J, Lee MK, Lee JH, Sohn SY. Thyroid Hormone Profile and Its Prognostic Impact on the Coronavirus Disease 2019 in Korean Patients. Endocrinol Metab (Seoul). 2021 Aug;36(4):769-777.  

● Sohn SY, Seo GH, Chung JH. Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study. Front Endocrinol (Lausanne). 2021 May 13;12:680647.   

● Sohn SY, Lee E, Lee MK, Lee JH. The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies. Endocrinol Metab (Seoul). 2020 Dec;35(4):786-800.

● Kim HJ, Kang T, Kang MJ, Ahn HS, Sohn SY.  Incidence and Mortality of Myocardial Infarction and Stroke in Patients with Hyperthyroidism: A Nationwide Cohort Study in Korea. Thyroid. 2020 Jul;30(7):955-965.  

● Sohn SY, Lee JJ, Lee JH. Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma. Pathol Oncol Res. 2020 Apr;26(2):927-936. 

● Cho A, Lee YK, Sohn SY. Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis. Medicine (Baltimore). 2020 Mar;99(10):e19473. 

● Sohn SY, Lee EK, Han SS, Lee YJ, Hwangbo Y, Kang YH, Lee SD, Kim SH, Woo SM, Lee WJ, Hong EK, Park SJ. Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer. Medicine (Baltimore). 2018 May;97(18):e0590. 

● Sohn SY, Kim HI, Kim YN, Kim TH, Kim SW, Chung JH. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up. Clin Endocrinol (oxf) 2018 Feb;88(2):318-326.

● Sohn SY, Kim YN, Kim HI, Kim SW, Chung JH. Validation of dynamic risk stratification in pediatric differentiated thyroid cancer. Endocrine 2017 Oct;58(1):167-175. 

● Sohn SY, Park WY, Shin HT, Bae JS, Ki CS, Oh YL, Kim SW, Chung JH. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer. Thyroid. 2016 May;26(5):672-82. 

● Sohn SY, Jang HW, Cho YY, Kim SW, Chung JH. Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective. Endocrinol Metab (Seoul). 2015 Dec;30(4):531-42 

● Sohn SY, Cho YY, Park SM, Jin SM, Chung JH, Kim SW. Weight changes in patients with differentiated thyroid carcinoma during postoperative long-term follow-up under TSH suppression. Endocrinol Metab (Seoul). 2015 Sep;30(3):343-51 

● Sohn SY, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. Thyroid. 2014 May;24(5):872-7. 

● Sohn SY, Kim HJ, Jang HW, Kim SW, Chung JH. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas. Head Neck. 2013 36(1):43-6. 

● Sohn SY, Choi JY, Jang HW, Kim HJ, Jin SM, Kim SW, Suh S, Hur KY, Kim JH, Chung JH, Kim SW. Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer. Thyroid. 2013 Jun;23(6):741-7. 

● Sohn SY, Kim HJ, Jang HW, Kim SW, Chung JH. Usefulness of Measurement of Serum Iodine Level to Assess the Appropriate Low Iodine Diet Preparation. J Korean Thyroid Assoc. 2012 Nov;5(2):143-147.